AI assistant
HEALIUS LIMITED — Capital/Financing Update 2021
Sep 20, 2021
65058_rns_2021-09-20_9881738b-73fa-46ef-aa07-108e159907ef.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ASX ANNOUNCEMENT
21 September 2021: VIRTUS HEALTH LIMITED (ASX: VRT)
Update on acquisition of Adora Fertility and Day Hospitals
Sydney, Australia - On 23 August 2021, Virtus Health, (“Virtus”, ASX:VRT) announced that it had entered into a share sale agreement to acquire Adora Fertility and three day hospitals (“the Adora Businesses”) from Healius Limited (ASX:HLS).
At the time of announcing the transaction, Virtus notified the Australian Competition and Consumer Commission (“ACCC”) of the acquisition. The ACCC has now advised that they intend to conduct a public review in relation to the acquisition. Virtus is working constructively with the ACCC to achieve a timely outcome.
The acquisition is not subject to regulatory approvals and Virtus does not expect the timing of completion in 2QFY2022 to change.
Authorised by the Board of Directors of Virtus Health.
- ENDS –
For further information, please contact:
Investor Enquiries:
Matt Prior CFO, Virtus Health +61 (0)498 003 973 [email protected]
Media Enquiries:
Angela Read PR and Media Specialist, Virtus Health +61 (0)428 448 719 [email protected]
About Virtus Health Limited
Virtus Health Limited (ASX:VRT) brings together leading clinicians, scientists, researchers and support staff to provide the very best in fertility care and related specialised diagnostic and day hospital services. We have one of the most successful medical collaborations in the world, with 128 leading fertility specialists supported by over 1,300 professional staff.